Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

In vivo biocompatibility evaluation of Cibacron blue–agarose

In vivo biocompatibility evaluation of Cibacron blue–agarose This study investigated the biocompatibility of Cibacron blue–agarose as a biomaterial for microencapsulation. Cibacron blue–agarose is known to have an affinity for albumin under certain pH conditions and in the proper steric environment. Thus it was postulated that the material's high affinity for host albumin might reduce a secondary immune response and reduce the fibrotic overgrowth that often accompanies transplanted foreign materials. In vivo tests were performed using the Lewis rat model. Both Cibacron blue–agarose and plain agarose disks were prepared, with some disks from each group being pre‐exposed to sera from Lewis rats. The disks were transplanted into the peritoneal cavities of Lewis rats. After 115 days the disks were excised. Fibrotic overgrowth was analyzed using light microscopy, and a blind study was used to measure the average growth thickness on each disk. The results demonstrated that all disks developed some fibrotic encapsulation and that the presence of Cibacron blue was not significant in reducing fibrotic overgrowth (p = 0.62). Agarose disks pre‐exposed to sera had significantly less average overgrowth than any other group (p = 0.06). © 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 47, 537–542, 1999. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Biomedical Materials Research Part A Wiley

In vivo biocompatibility evaluation of Cibacron blue–agarose

Download PDF
6 pages

Loading next page...
 
/lp/wiley/in-vivo-biocompatibility-evaluation-of-cibacron-blue-agarose-CHMII53kJ7

References (14)

Publisher
Wiley
Copyright
Copyright © 1999 Wiley Subscription Services, Inc., A Wiley Company
ISSN
1549-3296
eISSN
1552-4965
DOI
10.1002/(SICI)1097-4636(19991215)47:4<537::AID-JBM10>3.0.CO;2-I
Publisher site
See Article on Publisher Site

Abstract

This study investigated the biocompatibility of Cibacron blue–agarose as a biomaterial for microencapsulation. Cibacron blue–agarose is known to have an affinity for albumin under certain pH conditions and in the proper steric environment. Thus it was postulated that the material's high affinity for host albumin might reduce a secondary immune response and reduce the fibrotic overgrowth that often accompanies transplanted foreign materials. In vivo tests were performed using the Lewis rat model. Both Cibacron blue–agarose and plain agarose disks were prepared, with some disks from each group being pre‐exposed to sera from Lewis rats. The disks were transplanted into the peritoneal cavities of Lewis rats. After 115 days the disks were excised. Fibrotic overgrowth was analyzed using light microscopy, and a blind study was used to measure the average growth thickness on each disk. The results demonstrated that all disks developed some fibrotic encapsulation and that the presence of Cibacron blue was not significant in reducing fibrotic overgrowth (p = 0.62). Agarose disks pre‐exposed to sera had significantly less average overgrowth than any other group (p = 0.06). © 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 47, 537–542, 1999.

Journal

Journal of Biomedical Materials Research Part A – Wiley

Published: Mar 15, 2000

Keywords: ; ; ; ; ;

There are no references for this article.